Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Gettysburg, PA, Oct. 18, 2017 -- Genoa, a QoL Healthcare company, the nation’s leading behavioral health pharmacy and telepsychiatry company, announced today that it will host a live, complimentary executive web briefing titled, “100,000 Visits Later: Lessons on Building a Sustainable Telepsychiatry Program,” on Thursday, Nov. 2 at 2:00 p.m. ET. The web briefing will offer expert, best-practice advice from Samir Malik, general manager of Genoa Telepsychiatry.
“With more than 50 state-run Medicaid programs in the U.S., understanding the reimbursement environment for telepsychiatry is required to build a good program,” said Malik. “In addition to navigating the various reimbursement rates set by each state, one also has to understand regulatory requirements around what types of care can be delivered, in what settings, by whom, and under what conditions. All of these factors can seem intimidating, but need not be with the right understanding.”
Moderated by OPEN MINDS, the webinar will provide information on the favorability of the telepsychiatry market in all 50 states, as ranked by gross reimbursement potential; flexibility in location of service delivered; an unmet need for adults; an unmet need for children; and any restrictions on licensing.
The informative executive web briefing will specifically cover:
- The current reimbursement environment for telepsychiatry; and
- How to build a financially sustainable telepsychiatry program.
To learn more about this executive web briefing, or take advantage of free online registration, please visit: https://www.openminds.com/event/100000-visits-later-lessons-building-sustainable-telepsychiatry-programs/. All registrants will receive (at no charge and regardless of attendance) a recording of the webinar and an electronic copy of the presentation slides at its conclusion.
* * *
ABOUT Genoa Telepsychiatry
Genoa, a QoL Healthcare Company is the leading pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment communities for over 15 years. Our pharmacy and telepsychiatry services impact more than 550,000 individuals annually in 45 states and the District of Columbia. Our network of 380 pharmacies fills over 13 million prescriptions annually. For more information visit https://genoatelepsychiatry.com.
ABOUT OPEN MINDS
OPEN MINDS is a national health and human service industry market intelligence firm. Founded in 1987 and based in Gettysburg, Pennsylvania, the 75+ associates provide innovative management solutions designed to improve operational and strategic performance. Learn more at www.openminds.com.
OPEN MINDS Executive Education Events Team OPEN MINDS 7173341329 [email protected]
